HomeBNTX • NASDAQ
add
BioNTech
$112.78
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$112.78
Sarado: Ago 13, 4:05:07 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$111.00
Sakop ng araw
$111.50 - $113.39
Sakop ng taon
$81.20 - $131.49
Market cap
27.06B USD
Average na Volume
683.86K
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 260.80M | 102.64% |
Gastos sa pagpapatakbo | 621.10M | -39.74% |
Net na kita | -386.60M | 52.14% |
Net profit margin | -148.24 | 76.38% |
Kita sa bawat share | -1.60 | 52.38% |
EBITDA | -385.70M | 57.70% |
Aktuwal na % ng binabayarang buwis | 4.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.04B | -18.84% |
Kabuuang asset | 21.64B | -2.70% |
Kabuuang sagutin | 3.13B | -1.05% |
Kabuuang equity | 18.51B | — |
Natitirang share | 240.40M | — |
Presyo para makapag-book | 1.44 | — |
Return on assets | -5.10% | — |
Return on capital | -5.75% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -386.60M | 52.14% |
Cash mula sa mga operasyon | 146.50M | -91.00% |
Cash mula sa pag-invest | -64.40M | 73.32% |
Cash mula sa financing | -13.30M | 41.92% |
Net change in cash | 84.60M | -93.96% |
Malayang cash flow | -292.96M | -116.69% |
Tungkol
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
CEO
Itinatag
2008
Website
Mga Empleyado
6,772
